Your English writing platform
Discover LudwigExact(60)
Cytotoxic chemotherapy has been extensively studied in metastatic RCC (mRCC).
Sorafenib has proven efficacy in metastatic renal cell carcinoma (mRCC).
Targeted therapy has become the mainstay of treatment for mRCC.
Over the last decade, the treatment landscape of metastatic renal cell carcinoma (mRCC) has evolved tremendously.
The only targeted therapy for mRCC currently reimbursed in Serbia is sunitinib.
However, the prognostic utility of best tumor response in metastatic renal cell carcinoma (mRCC) remains vague.
Recently, several targeted agents have demonstrated clinical efficacy in the treatment of mRCC.
For patients with metastatic renal cell cancer (mRCC), treatment choice is mainly based on clinical parameters.
The outcome of patients with mRCC has been improved since the advent of targeted therapy.
Several targeted agents have demonstrated clinical efficacy in the treatment of metastatic renal cell carcinoma (mRCC).
Given how well suited to the task the Phoenix was, it was inevitable that MRCC would eventually ask it to help.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com